Advertisement
Screener

FUNCTIONAL BRANDS INC. (MEHA) Operating Lease, Right-of-Use Asset, Amortization Expense

FUNCTIONAL BRANDS INC. Operating Lease, Right-of-Use Asset, Amortization Expense

FUNCTIONAL BRANDS INC. (MEHA) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $177.82 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Cash Flow › Operating Activities

us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-08-14

  • FUNCTIONAL BRANDS INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-06-30 was $89.94K, a 9.47% increase year-over-year.
  • FUNCTIONAL BRANDS INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-03-31 was $87.88K, a 9.36% increase year-over-year.
  • FUNCTIONAL BRANDS INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-12-31 was $85.89K, a 8.69% increase year-over-year.
  • FUNCTIONAL BRANDS INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-30 was $84.00K.
  • FUNCTIONAL BRANDS INC. operating lease, right-of-use asset, amortization expense for fiscal 2025 was $332.40K, a 8.30% increase from fiscal 2024.
  • FUNCTIONAL BRANDS INC. operating lease, right-of-use asset, amortization expense for fiscal 2024 was $306.94K.
Period endOperating Lease, Right-of-Use Asset, Amortization Expense 3 monthOperating Lease, Right-of-Use Asset, Amortization Expense 6 monthOperating Lease, Right-of-Use Asset, Amortization Expense 9 monthOperating Lease, Right-of-Use Asset, Amortization Expense 12 month
2026-06-30$89.94K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14
$177.82K
10-Q · filed 2026-08-14
$263.71K
derived: sum of 3 quarters · filed 2026-08-14
$347.71K
derived: sum of 4 quarters · filed 2026-08-14
2026-03-31$87.88K
10-Q · filed 2026-05-15
$173.77K
derived: sum of 2 quarters · filed 2026-05-15
$257.77K
derived: sum of 3 quarters · filed 2026-05-15
$339.92K
derived: sum of 4 quarters · filed 2026-08-14
2025-12-31$85.89K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27
$169.89K
derived: sum of 2 quarters · filed 2026-03-27
$252.04K
derived: sum of 3 quarters · filed 2026-08-14
$332.40K
10-K · filed 2026-03-27
2025-09-30$84.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-12-15
$166.16K
derived: sum of 2 quarters · filed 2026-08-14
$246.51K
10-Q · filed 2025-12-15
$325.53K
derived: sum of 4 quarters · filed 2026-08-14
2025-06-30$82.16K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14
$162.51K
10-Q · filed 2026-08-14
$241.53K
derived: sum of 3 quarters · filed 2026-08-14
2025-03-31$80.36K
10-Q · filed 2026-05-15
$159.38K
derived: sum of 2 quarters · filed 2026-05-15
2024-12-31$79.02K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27
$306.94K
10-K · filed 2026-03-27
2024-09-30$227.91K
10-Q · filed 2025-12-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
Synergy CHC Corp. (SNYR)United States$0.001B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
MANNATECH INC (MTEX)United States$0.014B
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Canopy Growth Corp (CGC)$0.395B
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87